Its mRNA was found downregulated in pancreatic cancer samples and a fraction of the loss of MLH1 mRNA expression in pancreatic cancers has been attributed to promoter hypermethylation [62]. The gene discussed is MLH1; the disease is pancreatic neoplasm.